CRISPR Therapeutics (CRSP) Profit Margin (2016 - 2026)
CRISPR Therapeutics (CRSP) profit margin from Mar 31, 2016 to Mar 31, 2026. The current CRISPR Therapeutics (CRSP) profit margin is -8419.86%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of CRISPR Therapeutics (CRSP)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -16569.80% | +1587.97% |
| 2024 | -981.64% | +2272.21% |
| 2023 | -41.38% | -99.92% |
| 2022 | -54180.83% | -131364.35% |
| 2021 | 41.28% | -100.09% |
| 2020 | -48452.78% | -209963.00% |
| 2019 | 23.09% | -64.65% |
| 2019 | 65.31% | -100.39% |
| 2019 | -16781.25% | +14.39% |
| 2019 | -14669.70% | +177.42% |
| 2018 | -5287.82% | -41.61% |
| 2018 | -9055.36% | +157.17% |
| 2018 | -3521.10% | +69.21% |
| 2018 | -2080.88% | +1148.04% |
| 2017 | -166.73% | -83.87% |
| 2017 | -1033.89% | +65.90% |
| 2017 | -623.18% | -21.63% |
| 2017 | -795.19% | +77.01% |
| 2016 | -449.22% | -52.57% |
| 2016 | -947.10% | -55.85% |
| 2016 | -2145.00% | +21.99% |
| 2016 | -1758.33% | -82.76% |
| 2015 | -10200.00% | N/A |
Comparison CRISPR Therapeutics (CRSP) profit margin with competitors
CRISPR Therapeutics (CRSP) profit margin is -8419.86%.